David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 27,700 shares at $32.73 ($902K) on 2021-06-07, disclosed to the SEC on 2021-06-09.
Open-market sale of $902k PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.35 | 1,400 | $42K | 4.7% |
| 2 | $31.62 | 900 | $28K | 3.2% |
| 3 | $32.73 | 12,700 | $416K | 46.1% |
| 4 | $32.73 | 12,700 | $416K | 46.1% |
| Total | $32.57 avg | 27,700 | $902K | 100% |
| Filing → |
| PRLD | SELL | 2021-08-09 | $930K | — | Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-05-10 | $1.2M | — | Filing → |